End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
284,500 KRW | -0.52% |
|
+9.63% | +188.83% |
2023 | Alteogen Inc. Announces Clinical Trial of Tergase Showed Zero Incidence of ADA | CI |
2023 | ALTEOGEN Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ALTEOGEN INC. | Biopharmaceuticals | -0.52% | +9.63% | +188.83% | +577.38% | +3,070.90% | 10.92B | ![]() | ![]() | ![]() |
- Stock Market
- Equities
- A196170 Stock
- Charts ALTEOGEN Inc.
- Relative Strength Chart